Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
This study has been completed.
National Institute of Dental and Craniofacial Research (NIDCR)
Information provided by:
National Institutes of Health Clinical Center (CC)
First received: November 3, 1999
Last updated: June 30, 2017
Last verified: May 2, 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2, 2011|
|Primary Completion Date:||August 19, 2007 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, Bianco P, Robey PG, Collins MT. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014 Nov;99(11):4133-40. doi: 10.1210/jc.2014-1371. Epub 2014 Jul 17.